PLAGL1 and pancreatic adenocarcinoma: In conclusion, the present study detected the differential expression of PLAG family genes in PAAD patients and suggested that downregulated PLAGL1 might act as a biomarker in predicting poor prognosis and one of important factors in increasing cell proliferation in PAAD.